BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Zhou JH, Yin XL, Wang FY. Treatment of hepatitis B virus-associated glomerulonephritis: A meta-analysis. World J Gastroenterol 2010; 16(6): 770-777 [PMID: 20135728 DOI: 10.3748/wjg.v16.i6.770] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Xu G, Huang T. Hepatitis B virus-associated glomerular nephritis in East Asia: progress and challenges. Eur J Intern Med 2011;22:161-6. [PMID: 21402246 DOI: 10.1016/j.ejim.2010.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
2 Liu T, Yang S, Yue Z, Kuang Y, Guan W, Sun L. Clinical and pathological characteristics of 5 children with HBV surface antigen (HBsAg)-negative hepatitis B virus-associated glomerulonephritis. J Clin Virol 2015;66:1-5. [PMID: 25866326 DOI: 10.1016/j.jcv.2015.02.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Chen YC, Li CY, Tsai SJ, Chen YC. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection. World J Gastroenterol 2018; 24(8): 917-928 [PMID: 29491685 DOI: 10.3748/wjg.v24.i8.917] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
4 Fu B, Ji Y, Hu S, Ren T, Bhuva MS, Li G, Yang H. Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis. PLoS One 2020;15:e0227532. [PMID: 31940324 DOI: 10.1371/journal.pone.0227532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 熊清芳, 杨永峰. HBV相关性肾炎的抗病毒治疗. 世界华人消化杂志 2011; 19(15): 1620-1623 [DOI: 10.11569/wcjd.v19.i15.1620] [Reference Citation Analysis]
6 Zheng XY, Wei RB, Tang L, Li P, Zheng XD. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis. World J Gastroenterol 2012; 18(8): 821-832 [PMID: 22371643 DOI: 10.3748/wjg.v18.i8.821] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
7 杨道坤, 孙屹峰, 梁海军, 申保生, 乔汉臣. 复方甘草酸苷联合拉米夫定治疗乙型肝炎相关性肾炎40例. 世界华人消化杂志 2010; 18(13): 1380-1383 [DOI: 10.11569/wcjd.v18.i13.1380] [Reference Citation Analysis]
8 Pipili CL, Papatheodoridis GV, Cholongitas EC. Treatment of hepatitis B in patients with chronic kidney disease. Kidney Int. 2013;84:880-885. [PMID: 23783238 DOI: 10.1038/ki.2013.249] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
9 Peng T, Xie T, Liu L, Zhen J, Yang X. Analysis of clinical features and pathology of serum HBsAg positive glomerulonephritis. J Med Virol 2018;90:612-5. [PMID: 28975633 DOI: 10.1002/jmv.24959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Ladapo TA, Onifade EU, Lesi AE, Lesi OA. Successful Treatment of Hepatitis B Virus Associated Nephrotic Syndrome With Oral Lamivudine in a Nigerian Child: A Case Report. Journal of Tropical Pediatrics 2012;58:157-8. [DOI: 10.1093/tropej/fmr046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Mou S, Li J, Yu Z, Wang Q, Ni Z. Keto acid-supplemented low-protein diet for treatment of adult patients with hepatitis B virus infection and chronic glomerulonephritis. J Int Med Res 2013;41:129-37. [DOI: 10.1177/0300060512474758] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
12 Fabrizi F, Cerutti R, Ridruejo E. Hepatitis B virus infection as a risk factor for chronic kidney disease. Expert Rev Clin Pharmacol 2019;12:867-74. [PMID: 31456441 DOI: 10.1080/17512433.2019.1657828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Malik R, Hardikar W. Hepatitis B and C in Children. Indian J Pediatr 2016;83:1303-10. [PMID: 27094777 DOI: 10.1007/s12098-016-2076-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
14 Yang Y, Ma YP, Chen DP, Zhuo L, Li WG. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy. PLoS One 2016;11:e0160437. [PMID: 27598699 DOI: 10.1371/journal.pone.0160437] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
15 Shah HH, Patel C, Jhaveri KD. Complete Remission of Hepatitis B Virus-Associated Nephrotic Syndrome from IgA Nephropathy Following Peginterferon Therapy. Renal Failure 2012;35:295-8. [DOI: 10.3109/0886022x.2012.745785] [Cited by in Crossref: 9] [Article Influence: 1.0] [Reference Citation Analysis]
16 Fang J, Li W, Tan Z, Li D. Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study. Int Urol Nephrol 2014;46:49-56. [PMID: 23756850 DOI: 10.1007/s11255-013-0480-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
17 Yan Z, Qiao B, Zhang H, Wang Y, Gou W. Effectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis: A 104-week pilot study. Medicine (Baltimore) 2018;97:e11716. [PMID: 30075577 DOI: 10.1097/MD.0000000000011716] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]